Metzger Associates Hired to Supplement Del-Immune V
Pure Research Products, maker of Del-Immune V, chooses Metzger Associates as its partner in strategic communications
BOULDER, CO, April 29, 2010 /24-7PressRelease/ -- Pure Research Products, LLC has selected Metzger Associates to develop and implement a strategic communications plan that includes traditional and social media initiatives as well as an online marketing campaign, Web site redesign, blogs and an updated e-commerce function.
Pure Research Products manufactures Del-Immune V, a unique probiotic-derived supplement made from a strain of Lactobacillus rhamnosus (DV strain). Research shows the supplement triggers the human immune system, improving the body's ability to combat disease and maintain good health.
"We're excited for the opportunity to help Del-Immune V capitalize on the research and manufacturing they've invested to make this one-of-a-kind supplement," said John Metzger, founder and CEO of Metzger Associates. "This company is ahead of the market curve in probiotics and immune research. We're employing a wide range of tactics to tell a very cool story of innovation that could impact the health of a lot of people in a positive way."
About Metzger Associates
Boulder-based Metzger Associates is the Rocky Mountain region's premier integrated strategic communications firm. Since 1991, Metzger Associates' social media methodology, capital strategies practice and keen focus on clients' business goals have created value for innovative growth companies ranging from the Fortune 500 to venture-backed startups. Metzger Associates has one of the nation's top track records in developing award-winning communications strategies - gaining the right exposure for clients at the right time. For more information, please visit www.metzger.com.
About Del-Immune V
Del-Immune V, distributed by Pure Research Products LLC (PRP) of Boulder, Colo., is a new type of probiotic-derived supplement that provides immediate immune system support. Del-Immune V represents the culmination of 50 years of research begun by Cold War-era Soviet Bloc scientists and Russian military bio-warfare troop protection programs. PRP obtained exclusive rights to manufacture, distribute and market the distinct Lactobacillus rhamnosus (DV strain) from its Russian partners in 2002. Del-Immune V is used by thousands and recommended by doctors around the world. For more information, please visit www.del-immune.com.
Press Release Contact Information:
Amy Little
Metzger Associates
Account Coordinator
5733 Central Ave
Boulder, CO
USA 80301
Voice: 303-786-7000
Website: Visit Our Website
